PubRank

Pure aldosterone-secreting adrenocortical carcinoma in a patient with refractory primary hyperaldosteronism.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 4533278)

Published in Endocrinol Diabetes Metab Case Rep on July 21, 2015

Authors

S Hussain1, E Panteliou1, D M Berney2, R Carpenter3, M Matson4, A Sahdev4, M Bell5, E O'Sullivan5, W M Drake1

Author Affiliations

1: Department of Endocrinology, St Bartholomew's Hospital , London , UK.
2: Department of Pathology, St Bartholomew's Hospital , London , UK.
3: Department of Surgery, St Bartholomew's Hospital , London , UK.
4: Department of Radiology, St Bartholomew's Hospital , London , UK.
5: Department of Endocrinology, Galway University Hospital , Galway , UK.

Articles cited by this ↗

Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am J Surg Pathol (1984) 2.53

Approach to the patient with an adrenal incidentaloma. J Clin Endocrinol Metab (2010) 1.66

Weiss system revisited: a clinicopathologic and immunohistochemical study of 49 adrenocortical tumors. Am J Surg Pathol (2002) 1.60

Aldosterone-producing adrenocortical carcinoma: an unusual cause of Conn's syndrome with an ominous clinical course. Endocr Relat Cancer (2005) 1.20

Current and emerging therapeutic options in adrenocortical cancer treatment. J Oncol (2012) 0.99